K
KulrMeStoopid
Guest
3/5/2013
By Terry Baynes
(Reuters) - Pfizer Inc has agreed to settle the majority of lawsuits alleging its smoking cessation drug, Chantix, caused suicide and other injuries, the company said in its annual report filed with the Securities and Exchange Commission.
The United States' largest drugmaker has entered into agreements to settle around 80 percent of the more than 2,700 lawsuits over Chantix, costing the company around $273 million in 2012, according to the report filed on Feb. 28. Pfizer also said it has set aside $15 million to resolve all of the remaining claims in the United States.
Pfizer introduced Chantix in the United States in 2006, hoping it would become a multibillion-dollar product and revive flagging profits. But starting in 2008, consumers inundated the company with lawsuits claiming that Pfizer knew about psychological side effects related to the drug but failed to inform doctors and patients.
http://newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Pfizer_settles_suits_over_anti-smoking_drug_for_$273_mln/
By Terry Baynes
(Reuters) - Pfizer Inc has agreed to settle the majority of lawsuits alleging its smoking cessation drug, Chantix, caused suicide and other injuries, the company said in its annual report filed with the Securities and Exchange Commission.
The United States' largest drugmaker has entered into agreements to settle around 80 percent of the more than 2,700 lawsuits over Chantix, costing the company around $273 million in 2012, according to the report filed on Feb. 28. Pfizer also said it has set aside $15 million to resolve all of the remaining claims in the United States.
Pfizer introduced Chantix in the United States in 2006, hoping it would become a multibillion-dollar product and revive flagging profits. But starting in 2008, consumers inundated the company with lawsuits claiming that Pfizer knew about psychological side effects related to the drug but failed to inform doctors and patients.
http://newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Pfizer_settles_suits_over_anti-smoking_drug_for_$273_mln/